Global IVD Infectious Disease Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global IVD Infectious Disease market size was valued at USD 4490.3 million in 2023 and is forecast to a readjusted size of USD 7715 million by 2030 with a CAGR of 8.0% during review period.
In Vitro Diagnosis, or IVD (In Vitro Diagnosis), refers to the product and service of disease or body function that is obtained by testing human samples (blood, body fluids, tissues, etc.).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the IVD Infectious Disease industry chain, the market status of Personal (Biochemical Diagnosis, Immune Diagnosis), Commercial (Biochemical Diagnosis, Immune Diagnosis), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of IVD Infectious Disease.
Regionally, the report analyzes the IVD Infectious Disease markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global IVD Infectious Disease market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the IVD Infectious Disease market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the IVD Infectious Disease industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Biochemical Diagnosis, Immune Diagnosis).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the IVD Infectious Disease market.
Regional Analysis: The report involves examining the IVD Infectious Disease market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the IVD Infectious Disease market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to IVD Infectious Disease:
Company Analysis: Report covers individual IVD Infectious Disease players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards IVD Infectious Disease This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Personal, Commercial).
Technology Analysis: Report covers specific technologies relevant to IVD Infectious Disease. It assesses the current state, advancements, and potential future developments in IVD Infectious Disease areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the IVD Infectious Disease market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
IVD Infectious Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe IVD Infectious Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of IVD Infectious Disease, with revenue, gross margin and global market share of IVD Infectious Disease from 2019 to 2024.
Chapter 3, the IVD Infectious Disease competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and IVD Infectious Disease market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of IVD Infectious Disease.
Chapter 13, to describe IVD Infectious Disease research findings and conclusion.
In Vitro Diagnosis, or IVD (In Vitro Diagnosis), refers to the product and service of disease or body function that is obtained by testing human samples (blood, body fluids, tissues, etc.).
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the IVD Infectious Disease industry chain, the market status of Personal (Biochemical Diagnosis, Immune Diagnosis), Commercial (Biochemical Diagnosis, Immune Diagnosis), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of IVD Infectious Disease.
Regionally, the report analyzes the IVD Infectious Disease markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global IVD Infectious Disease market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the IVD Infectious Disease market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the IVD Infectious Disease industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Biochemical Diagnosis, Immune Diagnosis).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the IVD Infectious Disease market.
Regional Analysis: The report involves examining the IVD Infectious Disease market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the IVD Infectious Disease market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to IVD Infectious Disease:
Company Analysis: Report covers individual IVD Infectious Disease players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards IVD Infectious Disease This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Personal, Commercial).
Technology Analysis: Report covers specific technologies relevant to IVD Infectious Disease. It assesses the current state, advancements, and potential future developments in IVD Infectious Disease areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the IVD Infectious Disease market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
IVD Infectious Disease market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Biochemical Diagnosis
- Immune Diagnosis
- Molecular Diagnosis
- Microbiological Diagnosis
- Urine Diagnosis
- Coagulation Diagnosis
- Other
- Personal
- Commercial
- Academic
- Other
- Roche Diagnostics
- Abbott Laboratories
- Gen-Probe
- Becton Dickinson (BD)
- Bio-Rad Laboratories
- Siemens Healthcare
- Biomйrieux
- Danaher
- Thermo Fisher
- Sysmex
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe IVD Infectious Disease product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of IVD Infectious Disease, with revenue, gross margin and global market share of IVD Infectious Disease from 2019 to 2024.
Chapter 3, the IVD Infectious Disease competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and IVD Infectious Disease market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of IVD Infectious Disease.
Chapter 13, to describe IVD Infectious Disease research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of IVD Infectious Disease
1.2 Market Estimation Caveats and Base Year
1.3 Classification of IVD Infectious Disease by Type
1.3.1 Overview: Global IVD Infectious Disease Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global IVD Infectious Disease Consumption Value Market Share by Type in 2023
1.3.3 Biochemical Diagnosis
1.3.4 Immune Diagnosis
1.3.5 Molecular Diagnosis
1.3.6 Microbiological Diagnosis
1.3.7 Urine Diagnosis
1.3.8 Coagulation Diagnosis
1.3.9 Other
1.4 Global IVD Infectious Disease Market by Application
1.4.1 Overview: Global IVD Infectious Disease Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Personal
1.4.3 Commercial
1.4.4 Academic
1.4.5 Other
1.5 Global IVD Infectious Disease Market Size & Forecast
1.6 Global IVD Infectious Disease Market Size and Forecast by Region
1.6.1 Global IVD Infectious Disease Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global IVD Infectious Disease Market Size by Region, (2019-2030)
1.6.3 North America IVD Infectious Disease Market Size and Prospect (2019-2030)
1.6.4 Europe IVD Infectious Disease Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific IVD Infectious Disease Market Size and Prospect (2019-2030)
1.6.6 South America IVD Infectious Disease Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa IVD Infectious Disease Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Roche Diagnostics
2.1.1 Roche Diagnostics Details
2.1.2 Roche Diagnostics Major Business
2.1.3 Roche Diagnostics IVD Infectious Disease Product and Solutions
2.1.4 Roche Diagnostics IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Diagnostics Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories IVD Infectious Disease Product and Solutions
2.2.4 Abbott Laboratories IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 Gen-Probe
2.3.1 Gen-Probe Details
2.3.2 Gen-Probe Major Business
2.3.3 Gen-Probe IVD Infectious Disease Product and Solutions
2.3.4 Gen-Probe IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Gen-Probe Recent Developments and Future Plans
2.4 Becton Dickinson (BD)
2.4.1 Becton Dickinson (BD) Details
2.4.2 Becton Dickinson (BD) Major Business
2.4.3 Becton Dickinson (BD) IVD Infectious Disease Product and Solutions
2.4.4 Becton Dickinson (BD) IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Becton Dickinson (BD) Recent Developments and Future Plans
2.5 Bio-Rad Laboratories
2.5.1 Bio-Rad Laboratories Details
2.5.2 Bio-Rad Laboratories Major Business
2.5.3 Bio-Rad Laboratories IVD Infectious Disease Product and Solutions
2.5.4 Bio-Rad Laboratories IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.6 Siemens Healthcare
2.6.1 Siemens Healthcare Details
2.6.2 Siemens Healthcare Major Business
2.6.3 Siemens Healthcare IVD Infectious Disease Product and Solutions
2.6.4 Siemens Healthcare IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Siemens Healthcare Recent Developments and Future Plans
2.7 Biomйrieux
2.7.1 Biomйrieux Details
2.7.2 Biomйrieux Major Business
2.7.3 Biomйrieux IVD Infectious Disease Product and Solutions
2.7.4 Biomйrieux IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Biomйrieux Recent Developments and Future Plans
2.8 Danaher
2.8.1 Danaher Details
2.8.2 Danaher Major Business
2.8.3 Danaher IVD Infectious Disease Product and Solutions
2.8.4 Danaher IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Danaher Recent Developments and Future Plans
2.9 Thermo Fisher
2.9.1 Thermo Fisher Details
2.9.2 Thermo Fisher Major Business
2.9.3 Thermo Fisher IVD Infectious Disease Product and Solutions
2.9.4 Thermo Fisher IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Thermo Fisher Recent Developments and Future Plans
2.10 Sysmex
2.10.1 Sysmex Details
2.10.2 Sysmex Major Business
2.10.3 Sysmex IVD Infectious Disease Product and Solutions
2.10.4 Sysmex IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Sysmex Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global IVD Infectious Disease Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of IVD Infectious Disease by Company Revenue
3.2.2 Top 3 IVD Infectious Disease Players Market Share in 2023
3.2.3 Top 6 IVD Infectious Disease Players Market Share in 2023
3.3 IVD Infectious Disease Market: Overall Company Footprint Analysis
3.3.1 IVD Infectious Disease Market: Region Footprint
3.3.2 IVD Infectious Disease Market: Company Product Type Footprint
3.3.3 IVD Infectious Disease Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global IVD Infectious Disease Consumption Value and Market Share by Type (2019-2024)
4.2 Global IVD Infectious Disease Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global IVD Infectious Disease Consumption Value Market Share by Application (2019-2024)
5.2 Global IVD Infectious Disease Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America IVD Infectious Disease Consumption Value by Type (2019-2030)
6.2 North America IVD Infectious Disease Consumption Value by Application (2019-2030)
6.3 North America IVD Infectious Disease Market Size by Country
6.3.1 North America IVD Infectious Disease Consumption Value by Country (2019-2030)
6.3.2 United States IVD Infectious Disease Market Size and Forecast (2019-2030)
6.3.3 Canada IVD Infectious Disease Market Size and Forecast (2019-2030)
6.3.4 Mexico IVD Infectious Disease Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe IVD Infectious Disease Consumption Value by Type (2019-2030)
7.2 Europe IVD Infectious Disease Consumption Value by Application (2019-2030)
7.3 Europe IVD Infectious Disease Market Size by Country
7.3.1 Europe IVD Infectious Disease Consumption Value by Country (2019-2030)
7.3.2 Germany IVD Infectious Disease Market Size and Forecast (2019-2030)
7.3.3 France IVD Infectious Disease Market Size and Forecast (2019-2030)
7.3.4 United Kingdom IVD Infectious Disease Market Size and Forecast (2019-2030)
7.3.5 Russia IVD Infectious Disease Market Size and Forecast (2019-2030)
7.3.6 Italy IVD Infectious Disease Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific IVD Infectious Disease Consumption Value by Type (2019-2030)
8.2 Asia-Pacific IVD Infectious Disease Consumption Value by Application (2019-2030)
8.3 Asia-Pacific IVD Infectious Disease Market Size by Region
8.3.1 Asia-Pacific IVD Infectious Disease Consumption Value by Region (2019-2030)
8.3.2 China IVD Infectious Disease Market Size and Forecast (2019-2030)
8.3.3 Japan IVD Infectious Disease Market Size and Forecast (2019-2030)
8.3.4 South Korea IVD Infectious Disease Market Size and Forecast (2019-2030)
8.3.5 India IVD Infectious Disease Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia IVD Infectious Disease Market Size and Forecast (2019-2030)
8.3.7 Australia IVD Infectious Disease Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America IVD Infectious Disease Consumption Value by Type (2019-2030)
9.2 South America IVD Infectious Disease Consumption Value by Application (2019-2030)
9.3 South America IVD Infectious Disease Market Size by Country
9.3.1 South America IVD Infectious Disease Consumption Value by Country (2019-2030)
9.3.2 Brazil IVD Infectious Disease Market Size and Forecast (2019-2030)
9.3.3 Argentina IVD Infectious Disease Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa IVD Infectious Disease Consumption Value by Type (2019-2030)
10.2 Middle East & Africa IVD Infectious Disease Consumption Value by Application (2019-2030)
10.3 Middle East & Africa IVD Infectious Disease Market Size by Country
10.3.1 Middle East & Africa IVD Infectious Disease Consumption Value by Country (2019-2030)
10.3.2 Turkey IVD Infectious Disease Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia IVD Infectious Disease Market Size and Forecast (2019-2030)
10.3.4 UAE IVD Infectious Disease Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 IVD Infectious Disease Market Drivers
11.2 IVD Infectious Disease Market Restraints
11.3 IVD Infectious Disease Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 IVD Infectious Disease Industry Chain
12.2 IVD Infectious Disease Upstream Analysis
12.3 IVD Infectious Disease Midstream Analysis
12.4 IVD Infectious Disease Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of IVD Infectious Disease
1.2 Market Estimation Caveats and Base Year
1.3 Classification of IVD Infectious Disease by Type
1.3.1 Overview: Global IVD Infectious Disease Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global IVD Infectious Disease Consumption Value Market Share by Type in 2023
1.3.3 Biochemical Diagnosis
1.3.4 Immune Diagnosis
1.3.5 Molecular Diagnosis
1.3.6 Microbiological Diagnosis
1.3.7 Urine Diagnosis
1.3.8 Coagulation Diagnosis
1.3.9 Other
1.4 Global IVD Infectious Disease Market by Application
1.4.1 Overview: Global IVD Infectious Disease Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Personal
1.4.3 Commercial
1.4.4 Academic
1.4.5 Other
1.5 Global IVD Infectious Disease Market Size & Forecast
1.6 Global IVD Infectious Disease Market Size and Forecast by Region
1.6.1 Global IVD Infectious Disease Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global IVD Infectious Disease Market Size by Region, (2019-2030)
1.6.3 North America IVD Infectious Disease Market Size and Prospect (2019-2030)
1.6.4 Europe IVD Infectious Disease Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific IVD Infectious Disease Market Size and Prospect (2019-2030)
1.6.6 South America IVD Infectious Disease Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa IVD Infectious Disease Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Roche Diagnostics
2.1.1 Roche Diagnostics Details
2.1.2 Roche Diagnostics Major Business
2.1.3 Roche Diagnostics IVD Infectious Disease Product and Solutions
2.1.4 Roche Diagnostics IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Diagnostics Recent Developments and Future Plans
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories IVD Infectious Disease Product and Solutions
2.2.4 Abbott Laboratories IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Abbott Laboratories Recent Developments and Future Plans
2.3 Gen-Probe
2.3.1 Gen-Probe Details
2.3.2 Gen-Probe Major Business
2.3.3 Gen-Probe IVD Infectious Disease Product and Solutions
2.3.4 Gen-Probe IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Gen-Probe Recent Developments and Future Plans
2.4 Becton Dickinson (BD)
2.4.1 Becton Dickinson (BD) Details
2.4.2 Becton Dickinson (BD) Major Business
2.4.3 Becton Dickinson (BD) IVD Infectious Disease Product and Solutions
2.4.4 Becton Dickinson (BD) IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Becton Dickinson (BD) Recent Developments and Future Plans
2.5 Bio-Rad Laboratories
2.5.1 Bio-Rad Laboratories Details
2.5.2 Bio-Rad Laboratories Major Business
2.5.3 Bio-Rad Laboratories IVD Infectious Disease Product and Solutions
2.5.4 Bio-Rad Laboratories IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Bio-Rad Laboratories Recent Developments and Future Plans
2.6 Siemens Healthcare
2.6.1 Siemens Healthcare Details
2.6.2 Siemens Healthcare Major Business
2.6.3 Siemens Healthcare IVD Infectious Disease Product and Solutions
2.6.4 Siemens Healthcare IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Siemens Healthcare Recent Developments and Future Plans
2.7 Biomйrieux
2.7.1 Biomйrieux Details
2.7.2 Biomйrieux Major Business
2.7.3 Biomйrieux IVD Infectious Disease Product and Solutions
2.7.4 Biomйrieux IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Biomйrieux Recent Developments and Future Plans
2.8 Danaher
2.8.1 Danaher Details
2.8.2 Danaher Major Business
2.8.3 Danaher IVD Infectious Disease Product and Solutions
2.8.4 Danaher IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Danaher Recent Developments and Future Plans
2.9 Thermo Fisher
2.9.1 Thermo Fisher Details
2.9.2 Thermo Fisher Major Business
2.9.3 Thermo Fisher IVD Infectious Disease Product and Solutions
2.9.4 Thermo Fisher IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Thermo Fisher Recent Developments and Future Plans
2.10 Sysmex
2.10.1 Sysmex Details
2.10.2 Sysmex Major Business
2.10.3 Sysmex IVD Infectious Disease Product and Solutions
2.10.4 Sysmex IVD Infectious Disease Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Sysmex Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global IVD Infectious Disease Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of IVD Infectious Disease by Company Revenue
3.2.2 Top 3 IVD Infectious Disease Players Market Share in 2023
3.2.3 Top 6 IVD Infectious Disease Players Market Share in 2023
3.3 IVD Infectious Disease Market: Overall Company Footprint Analysis
3.3.1 IVD Infectious Disease Market: Region Footprint
3.3.2 IVD Infectious Disease Market: Company Product Type Footprint
3.3.3 IVD Infectious Disease Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global IVD Infectious Disease Consumption Value and Market Share by Type (2019-2024)
4.2 Global IVD Infectious Disease Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global IVD Infectious Disease Consumption Value Market Share by Application (2019-2024)
5.2 Global IVD Infectious Disease Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America IVD Infectious Disease Consumption Value by Type (2019-2030)
6.2 North America IVD Infectious Disease Consumption Value by Application (2019-2030)
6.3 North America IVD Infectious Disease Market Size by Country
6.3.1 North America IVD Infectious Disease Consumption Value by Country (2019-2030)
6.3.2 United States IVD Infectious Disease Market Size and Forecast (2019-2030)
6.3.3 Canada IVD Infectious Disease Market Size and Forecast (2019-2030)
6.3.4 Mexico IVD Infectious Disease Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe IVD Infectious Disease Consumption Value by Type (2019-2030)
7.2 Europe IVD Infectious Disease Consumption Value by Application (2019-2030)
7.3 Europe IVD Infectious Disease Market Size by Country
7.3.1 Europe IVD Infectious Disease Consumption Value by Country (2019-2030)
7.3.2 Germany IVD Infectious Disease Market Size and Forecast (2019-2030)
7.3.3 France IVD Infectious Disease Market Size and Forecast (2019-2030)
7.3.4 United Kingdom IVD Infectious Disease Market Size and Forecast (2019-2030)
7.3.5 Russia IVD Infectious Disease Market Size and Forecast (2019-2030)
7.3.6 Italy IVD Infectious Disease Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific IVD Infectious Disease Consumption Value by Type (2019-2030)
8.2 Asia-Pacific IVD Infectious Disease Consumption Value by Application (2019-2030)
8.3 Asia-Pacific IVD Infectious Disease Market Size by Region
8.3.1 Asia-Pacific IVD Infectious Disease Consumption Value by Region (2019-2030)
8.3.2 China IVD Infectious Disease Market Size and Forecast (2019-2030)
8.3.3 Japan IVD Infectious Disease Market Size and Forecast (2019-2030)
8.3.4 South Korea IVD Infectious Disease Market Size and Forecast (2019-2030)
8.3.5 India IVD Infectious Disease Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia IVD Infectious Disease Market Size and Forecast (2019-2030)
8.3.7 Australia IVD Infectious Disease Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America IVD Infectious Disease Consumption Value by Type (2019-2030)
9.2 South America IVD Infectious Disease Consumption Value by Application (2019-2030)
9.3 South America IVD Infectious Disease Market Size by Country
9.3.1 South America IVD Infectious Disease Consumption Value by Country (2019-2030)
9.3.2 Brazil IVD Infectious Disease Market Size and Forecast (2019-2030)
9.3.3 Argentina IVD Infectious Disease Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa IVD Infectious Disease Consumption Value by Type (2019-2030)
10.2 Middle East & Africa IVD Infectious Disease Consumption Value by Application (2019-2030)
10.3 Middle East & Africa IVD Infectious Disease Market Size by Country
10.3.1 Middle East & Africa IVD Infectious Disease Consumption Value by Country (2019-2030)
10.3.2 Turkey IVD Infectious Disease Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia IVD Infectious Disease Market Size and Forecast (2019-2030)
10.3.4 UAE IVD Infectious Disease Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 IVD Infectious Disease Market Drivers
11.2 IVD Infectious Disease Market Restraints
11.3 IVD Infectious Disease Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 IVD Infectious Disease Industry Chain
12.2 IVD Infectious Disease Upstream Analysis
12.3 IVD Infectious Disease Midstream Analysis
12.4 IVD Infectious Disease Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global IVD Infectious Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global IVD Infectious Disease Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global IVD Infectious Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global IVD Infectious Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 6. Roche Diagnostics Major Business
Table 7. Roche Diagnostics IVD Infectious Disease Product and Solutions
Table 8. Roche Diagnostics IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Roche Diagnostics Recent Developments and Future Plans
Table 10. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories IVD Infectious Disease Product and Solutions
Table 13. Abbott Laboratories IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Abbott Laboratories Recent Developments and Future Plans
Table 15. Gen-Probe Company Information, Head Office, and Major Competitors
Table 16. Gen-Probe Major Business
Table 17. Gen-Probe IVD Infectious Disease Product and Solutions
Table 18. Gen-Probe IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Gen-Probe Recent Developments and Future Plans
Table 20. Becton Dickinson (BD) Company Information, Head Office, and Major Competitors
Table 21. Becton Dickinson (BD) Major Business
Table 22. Becton Dickinson (BD) IVD Infectious Disease Product and Solutions
Table 23. Becton Dickinson (BD) IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Becton Dickinson (BD) Recent Developments and Future Plans
Table 25. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 26. Bio-Rad Laboratories Major Business
Table 27. Bio-Rad Laboratories IVD Infectious Disease Product and Solutions
Table 28. Bio-Rad Laboratories IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Bio-Rad Laboratories Recent Developments and Future Plans
Table 30. Siemens Healthcare Company Information, Head Office, and Major Competitors
Table 31. Siemens Healthcare Major Business
Table 32. Siemens Healthcare IVD Infectious Disease Product and Solutions
Table 33. Siemens Healthcare IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Siemens Healthcare Recent Developments and Future Plans
Table 35. Biomйrieux Company Information, Head Office, and Major Competitors
Table 36. Biomйrieux Major Business
Table 37. Biomйrieux IVD Infectious Disease Product and Solutions
Table 38. Biomйrieux IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Biomйrieux Recent Developments and Future Plans
Table 40. Danaher Company Information, Head Office, and Major Competitors
Table 41. Danaher Major Business
Table 42. Danaher IVD Infectious Disease Product and Solutions
Table 43. Danaher IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Danaher Recent Developments and Future Plans
Table 45. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 46. Thermo Fisher Major Business
Table 47. Thermo Fisher IVD Infectious Disease Product and Solutions
Table 48. Thermo Fisher IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Thermo Fisher Recent Developments and Future Plans
Table 50. Sysmex Company Information, Head Office, and Major Competitors
Table 51. Sysmex Major Business
Table 52. Sysmex IVD Infectious Disease Product and Solutions
Table 53. Sysmex IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Sysmex Recent Developments and Future Plans
Table 55. Global IVD Infectious Disease Revenue (USD Million) by Players (2019-2024)
Table 56. Global IVD Infectious Disease Revenue Share by Players (2019-2024)
Table 57. Breakdown of IVD Infectious Disease by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in IVD Infectious Disease, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key IVD Infectious Disease Players
Table 60. IVD Infectious Disease Market: Company Product Type Footprint
Table 61. IVD Infectious Disease Market: Company Product Application Footprint
Table 62. IVD Infectious Disease New Market Entrants and Barriers to Market Entry
Table 63. IVD Infectious Disease Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global IVD Infectious Disease Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global IVD Infectious Disease Consumption Value Share by Type (2019-2024)
Table 66. Global IVD Infectious Disease Consumption Value Forecast by Type (2025-2030)
Table 67. Global IVD Infectious Disease Consumption Value by Application (2019-2024)
Table 68. Global IVD Infectious Disease Consumption Value Forecast by Application (2025-2030)
Table 69. North America IVD Infectious Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America IVD Infectious Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America IVD Infectious Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America IVD Infectious Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America IVD Infectious Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America IVD Infectious Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe IVD Infectious Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe IVD Infectious Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe IVD Infectious Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe IVD Infectious Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe IVD Infectious Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe IVD Infectious Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific IVD Infectious Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific IVD Infectious Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific IVD Infectious Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific IVD Infectious Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific IVD Infectious Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific IVD Infectious Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America IVD Infectious Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America IVD Infectious Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America IVD Infectious Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America IVD Infectious Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America IVD Infectious Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America IVD Infectious Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa IVD Infectious Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa IVD Infectious Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa IVD Infectious Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa IVD Infectious Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa IVD Infectious Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa IVD Infectious Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 99. IVD Infectious Disease Raw Material
Table 100. Key Suppliers of IVD Infectious Disease Raw Materials
Table 1. Global IVD Infectious Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global IVD Infectious Disease Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global IVD Infectious Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global IVD Infectious Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Roche Diagnostics Company Information, Head Office, and Major Competitors
Table 6. Roche Diagnostics Major Business
Table 7. Roche Diagnostics IVD Infectious Disease Product and Solutions
Table 8. Roche Diagnostics IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Roche Diagnostics Recent Developments and Future Plans
Table 10. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 11. Abbott Laboratories Major Business
Table 12. Abbott Laboratories IVD Infectious Disease Product and Solutions
Table 13. Abbott Laboratories IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Abbott Laboratories Recent Developments and Future Plans
Table 15. Gen-Probe Company Information, Head Office, and Major Competitors
Table 16. Gen-Probe Major Business
Table 17. Gen-Probe IVD Infectious Disease Product and Solutions
Table 18. Gen-Probe IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Gen-Probe Recent Developments and Future Plans
Table 20. Becton Dickinson (BD) Company Information, Head Office, and Major Competitors
Table 21. Becton Dickinson (BD) Major Business
Table 22. Becton Dickinson (BD) IVD Infectious Disease Product and Solutions
Table 23. Becton Dickinson (BD) IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Becton Dickinson (BD) Recent Developments and Future Plans
Table 25. Bio-Rad Laboratories Company Information, Head Office, and Major Competitors
Table 26. Bio-Rad Laboratories Major Business
Table 27. Bio-Rad Laboratories IVD Infectious Disease Product and Solutions
Table 28. Bio-Rad Laboratories IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Bio-Rad Laboratories Recent Developments and Future Plans
Table 30. Siemens Healthcare Company Information, Head Office, and Major Competitors
Table 31. Siemens Healthcare Major Business
Table 32. Siemens Healthcare IVD Infectious Disease Product and Solutions
Table 33. Siemens Healthcare IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Siemens Healthcare Recent Developments and Future Plans
Table 35. Biomйrieux Company Information, Head Office, and Major Competitors
Table 36. Biomйrieux Major Business
Table 37. Biomйrieux IVD Infectious Disease Product and Solutions
Table 38. Biomйrieux IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Biomйrieux Recent Developments and Future Plans
Table 40. Danaher Company Information, Head Office, and Major Competitors
Table 41. Danaher Major Business
Table 42. Danaher IVD Infectious Disease Product and Solutions
Table 43. Danaher IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Danaher Recent Developments and Future Plans
Table 45. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 46. Thermo Fisher Major Business
Table 47. Thermo Fisher IVD Infectious Disease Product and Solutions
Table 48. Thermo Fisher IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Thermo Fisher Recent Developments and Future Plans
Table 50. Sysmex Company Information, Head Office, and Major Competitors
Table 51. Sysmex Major Business
Table 52. Sysmex IVD Infectious Disease Product and Solutions
Table 53. Sysmex IVD Infectious Disease Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Sysmex Recent Developments and Future Plans
Table 55. Global IVD Infectious Disease Revenue (USD Million) by Players (2019-2024)
Table 56. Global IVD Infectious Disease Revenue Share by Players (2019-2024)
Table 57. Breakdown of IVD Infectious Disease by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in IVD Infectious Disease, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key IVD Infectious Disease Players
Table 60. IVD Infectious Disease Market: Company Product Type Footprint
Table 61. IVD Infectious Disease Market: Company Product Application Footprint
Table 62. IVD Infectious Disease New Market Entrants and Barriers to Market Entry
Table 63. IVD Infectious Disease Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global IVD Infectious Disease Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global IVD Infectious Disease Consumption Value Share by Type (2019-2024)
Table 66. Global IVD Infectious Disease Consumption Value Forecast by Type (2025-2030)
Table 67. Global IVD Infectious Disease Consumption Value by Application (2019-2024)
Table 68. Global IVD Infectious Disease Consumption Value Forecast by Application (2025-2030)
Table 69. North America IVD Infectious Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America IVD Infectious Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America IVD Infectious Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America IVD Infectious Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America IVD Infectious Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America IVD Infectious Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe IVD Infectious Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe IVD Infectious Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe IVD Infectious Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe IVD Infectious Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe IVD Infectious Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe IVD Infectious Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific IVD Infectious Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific IVD Infectious Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific IVD Infectious Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific IVD Infectious Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific IVD Infectious Disease Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific IVD Infectious Disease Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America IVD Infectious Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America IVD Infectious Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America IVD Infectious Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America IVD Infectious Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America IVD Infectious Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America IVD Infectious Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa IVD Infectious Disease Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa IVD Infectious Disease Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa IVD Infectious Disease Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa IVD Infectious Disease Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa IVD Infectious Disease Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa IVD Infectious Disease Consumption Value by Country (2025-2030) & (USD Million)
Table 99. IVD Infectious Disease Raw Material
Table 100. Key Suppliers of IVD Infectious Disease Raw Materials
LIST OF FIGURES
Figure 1. IVD Infectious Disease Picture
Figure 2. Global IVD Infectious Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global IVD Infectious Disease Consumption Value Market Share by Type in 2023
Figure 4. Biochemical Diagnosis
Figure 5. Immune Diagnosis
Figure 6. Molecular Diagnosis
Figure 7. Microbiological Diagnosis
Figure 8. Urine Diagnosis
Figure 9. Coagulation Diagnosis
Figure 10. Other
Figure 11. Global IVD Infectious Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 12. IVD Infectious Disease Consumption Value Market Share by Application in 2023
Figure 13. Personal Picture
Figure 14. Commercial Picture
Figure 15. Academic Picture
Figure 16. Other Picture
Figure 17. Global IVD Infectious Disease Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global IVD Infectious Disease Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Market IVD Infectious Disease Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 20. Global IVD Infectious Disease Consumption Value Market Share by Region (2019-2030)
Figure 21. Global IVD Infectious Disease Consumption Value Market Share by Region in 2023
Figure 22. North America IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 25. South America IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East and Africa IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 27. Global IVD Infectious Disease Revenue Share by Players in 2023
Figure 28. IVD Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 29. Global Top 3 Players IVD Infectious Disease Market Share in 2023
Figure 30. Global Top 6 Players IVD Infectious Disease Market Share in 2023
Figure 31. Global IVD Infectious Disease Consumption Value Share by Type (2019-2024)
Figure 32. Global IVD Infectious Disease Market Share Forecast by Type (2025-2030)
Figure 33. Global IVD Infectious Disease Consumption Value Share by Application (2019-2024)
Figure 34. Global IVD Infectious Disease Market Share Forecast by Application (2025-2030)
Figure 35. North America IVD Infectious Disease Consumption Value Market Share by Type (2019-2030)
Figure 36. North America IVD Infectious Disease Consumption Value Market Share by Application (2019-2030)
Figure 37. North America IVD Infectious Disease Consumption Value Market Share by Country (2019-2030)
Figure 38. United States IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 39. Canada IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 40. Mexico IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 41. Europe IVD Infectious Disease Consumption Value Market Share by Type (2019-2030)
Figure 42. Europe IVD Infectious Disease Consumption Value Market Share by Application (2019-2030)
Figure 43. Europe IVD Infectious Disease Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 45. France IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific IVD Infectious Disease Consumption Value Market Share by Type (2019-2030)
Figure 50. Asia-Pacific IVD Infectious Disease Consumption Value Market Share by Application (2019-2030)
Figure 51. Asia-Pacific IVD Infectious Disease Consumption Value Market Share by Region (2019-2030)
Figure 52. China IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 55. India IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 58. South America IVD Infectious Disease Consumption Value Market Share by Type (2019-2030)
Figure 59. South America IVD Infectious Disease Consumption Value Market Share by Application (2019-2030)
Figure 60. South America IVD Infectious Disease Consumption Value Market Share by Country (2019-2030)
Figure 61. Brazil IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 62. Argentina IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 63. Middle East and Africa IVD Infectious Disease Consumption Value Market Share by Type (2019-2030)
Figure 64. Middle East and Africa IVD Infectious Disease Consumption Value Market Share by Application (2019-2030)
Figure 65. Middle East and Africa IVD Infectious Disease Consumption Value Market Share by Country (2019-2030)
Figure 66. Turkey IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 67. Saudi Arabia IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 68. UAE IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 69. IVD Infectious Disease Market Drivers
Figure 70. IVD Infectious Disease Market Restraints
Figure 71. IVD Infectious Disease Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Manufacturing Cost Structure Analysis of IVD Infectious Disease in 2023
Figure 74. Manufacturing Process Analysis of IVD Infectious Disease
Figure 75. IVD Infectious Disease Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
Figure 1. IVD Infectious Disease Picture
Figure 2. Global IVD Infectious Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global IVD Infectious Disease Consumption Value Market Share by Type in 2023
Figure 4. Biochemical Diagnosis
Figure 5. Immune Diagnosis
Figure 6. Molecular Diagnosis
Figure 7. Microbiological Diagnosis
Figure 8. Urine Diagnosis
Figure 9. Coagulation Diagnosis
Figure 10. Other
Figure 11. Global IVD Infectious Disease Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 12. IVD Infectious Disease Consumption Value Market Share by Application in 2023
Figure 13. Personal Picture
Figure 14. Commercial Picture
Figure 15. Academic Picture
Figure 16. Other Picture
Figure 17. Global IVD Infectious Disease Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global IVD Infectious Disease Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Market IVD Infectious Disease Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 20. Global IVD Infectious Disease Consumption Value Market Share by Region (2019-2030)
Figure 21. Global IVD Infectious Disease Consumption Value Market Share by Region in 2023
Figure 22. North America IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 25. South America IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East and Africa IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 27. Global IVD Infectious Disease Revenue Share by Players in 2023
Figure 28. IVD Infectious Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 29. Global Top 3 Players IVD Infectious Disease Market Share in 2023
Figure 30. Global Top 6 Players IVD Infectious Disease Market Share in 2023
Figure 31. Global IVD Infectious Disease Consumption Value Share by Type (2019-2024)
Figure 32. Global IVD Infectious Disease Market Share Forecast by Type (2025-2030)
Figure 33. Global IVD Infectious Disease Consumption Value Share by Application (2019-2024)
Figure 34. Global IVD Infectious Disease Market Share Forecast by Application (2025-2030)
Figure 35. North America IVD Infectious Disease Consumption Value Market Share by Type (2019-2030)
Figure 36. North America IVD Infectious Disease Consumption Value Market Share by Application (2019-2030)
Figure 37. North America IVD Infectious Disease Consumption Value Market Share by Country (2019-2030)
Figure 38. United States IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 39. Canada IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 40. Mexico IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 41. Europe IVD Infectious Disease Consumption Value Market Share by Type (2019-2030)
Figure 42. Europe IVD Infectious Disease Consumption Value Market Share by Application (2019-2030)
Figure 43. Europe IVD Infectious Disease Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 45. France IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific IVD Infectious Disease Consumption Value Market Share by Type (2019-2030)
Figure 50. Asia-Pacific IVD Infectious Disease Consumption Value Market Share by Application (2019-2030)
Figure 51. Asia-Pacific IVD Infectious Disease Consumption Value Market Share by Region (2019-2030)
Figure 52. China IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 55. India IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 58. South America IVD Infectious Disease Consumption Value Market Share by Type (2019-2030)
Figure 59. South America IVD Infectious Disease Consumption Value Market Share by Application (2019-2030)
Figure 60. South America IVD Infectious Disease Consumption Value Market Share by Country (2019-2030)
Figure 61. Brazil IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 62. Argentina IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 63. Middle East and Africa IVD Infectious Disease Consumption Value Market Share by Type (2019-2030)
Figure 64. Middle East and Africa IVD Infectious Disease Consumption Value Market Share by Application (2019-2030)
Figure 65. Middle East and Africa IVD Infectious Disease Consumption Value Market Share by Country (2019-2030)
Figure 66. Turkey IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 67. Saudi Arabia IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 68. UAE IVD Infectious Disease Consumption Value (2019-2030) & (USD Million)
Figure 69. IVD Infectious Disease Market Drivers
Figure 70. IVD Infectious Disease Market Restraints
Figure 71. IVD Infectious Disease Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Manufacturing Cost Structure Analysis of IVD Infectious Disease in 2023
Figure 74. Manufacturing Process Analysis of IVD Infectious Disease
Figure 75. IVD Infectious Disease Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source
